Skip to content

Clinical trials

Phase 3 Chronic Urticaria trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Urticaria Phase: Phase 3 Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20082
20114
20121
20131
20144
20151
20171
20182
20192
20202
20214
20223
20234
20244
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Active, not recruiting7
Not yet recruiting2
Unknown status2
Recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals16
Celldex Therapeutics3
Charite University, Berlin, Germany3
Genentech, Inc.3
Sanofi2
UCB Pharma2
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.1
Cairo University1
Celltrion1
Chang Gung Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Urticaria43
Urticaria4
Angioedema2
Hypersensitivity2
Rhinitis, Allergic2
Rhinitis, Allergic, Seasonal2
Pruritus1

Trials

Showing 51 to 43 of 43. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.